Table 1 Patient characteristics
Before PsM | After PsM | ||||||
|---|---|---|---|---|---|---|---|
NQ group | Q group | p value | NQ group | Q group | p value | std | |
(N=352) | (N=65) | (N=49) | (N=49) | ||||
Age, years | 70 (24–98) | 73 (46–89) | 0.008 | 72 (38–90) | 73 (46–89) | 0.929 | 0.070 |
Sex | 0.422 | 0.686 | |||||
Male | 181 (51.4%) | 37 (56.9%) | 24 (49.0%) | 27 (55.1%) | − 0.123 | ||
Female | 171 (48.6%) | 28 (43.1%) | 25 (51.0%) | 22 (44.9%) | 0.123 | ||
BMI | 22.5 (14.2-38.5) | 23.4 (15.4-38.1) | 0.035 | 22.7 (14.4–30.2) | 23.3 (15.4–37.7) | 0.481 | − 0.143 |
ASA-PS | 0.037 | 0.245 | |||||
Class 1, 2 | 304 (86.4%) | 49 (75.4%) | 39 (79.6%) | 38 (77.6%) | 0.050 | ||
Class 3 | 48 (13.6%) | 16 (24.6%) | 10 (20.4%) | 11 (22.4%) | − 0.050 | ||
Tumour location | 0.495 | 0.834 | |||||
Right-sided | 147 (41.8%) | 24 (36.9%) | 19 (38.8%) | 17 (34.7%) | 0.085 | ||
Left-sided | 205 (58.2%) | 41 (63.1%) | 30 (61.2%) | 32 (65.3%) | − 0.085 | ||
Preoperative ileus | 0.349 | 1 | |||||
Yes | 57 (16.2%) | 7 (10.8%) | 6 (12.2%) | 7 (14.3%) | − 0.060 | ||
No | 295 (83.8%) | 58 (89.2%) | 43 (87.8%) | 42 (85.7%) | 0.060 | ||
Previous laparotomy | 0.259 | 1 | |||||
Yes | 75 (21.3%) | 18 (27.7%) | 12 (24.5%) | 12 (24.5%) | 0 | ||
No | 277 (78.7%) | 47 (72.3%) | 37 (75.5%) | 37 (75.5%) | 0 | ||
Adj chemo | 0.891 | 1 | |||||
Yes | 146 (41.5%) | 26 (40.0%) | 20 (40.8%) | 21 (42.9%) | − 0.041 | ||
No | 206 (58.5%) | 39 (60.0%) | 29 (59.2%) | 28 (57.1%) | 0.041 | ||
CEA, ng/ml | 3.2 (0.3–79.1) | 3.0 (0.6–44.0) | 0.499 | 2.7 (0.5–43.9) | 3.1 (0.6–44.0) | 0.529 | − 0.015 |
CA19-9, ng/ml | 7.0 (1.0–644.5) | 11.9 (1.0–1933.0) | 0.056 | 8.2 (1.0–644.5) | 11.9 (1.00–184.0) | 0.189 | − 0.137 |
pStage | 1 | 0.840 | |||||
pStage II | 163 (46.3%) | 30 (46.2%) | 23 (46.9%) | 25 (51.0%) | − 0.082 | ||
pStage III | 189 (53.7%) | 35 (53.8%) | 26 (53.1%) | 24 (49.0%) | 0.082 | ||
Histological type | 0.052 | 0.715 | |||||
Differentiated | 333 (94.6%) | 57 (87.7%) | 46 (93.9%) | 44 (89.8%) | 0.149 | ||
Undifferentiated | 19 (5.4%) | 8 (12.3%) | 3 (6.1%) | 5 (10.2%) | − 0.149 | ||
Tumour diameter, mm | 40.0 (2.0–117.0) | 45.0 (10.0–110.0) | 0.131 | 40.0 (12.0–117.0) | 45.0 (10.0–90.0) | 0.270 | − 0.144 |
Lymphatic invasion | 0.282 | 0.840 | |||||
Positive | 179 (50.9%) | 38 (58.5%) | 24 (49.0%) | 26 (53.1%) | − 0.082 | ||
Negative | 173 (49.1%) | 27 (41.5%) | 25 (51.0%) | 23 (46.9%) | 0.082 | ||
Vascular invasion | 0.132 | 0.684 | |||||
Positive | 211 (59.9%) | 32 (49.2%) | 29 (59.2%) | 26 (53.1%) | 0.124 | ||
Negative | 141 (40.1%) | 33 (50.8%) | 20 (40.8%) | 23 (46.9%) | − 0.124 | ||